Program for Appropriate Technology in Health:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Program for Appropriate Technology in Health - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10282
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other sexually transmitted infections, malaria, tuberculosis, epidemic and emerging diseases, women’s cancers, non communicable diseases, diabetes and neglected tropical diseases. PATH caters to governments, donors, and multilateral organizations. PATH collaborates with innovators, public and private-sector partners, governments, communities, and civil society groups to develop and introduce health solutions. The organization has operations in Belgium, Cambodia, China, Congo, Ethiopia, France, Ghana, India, Kenya, the US, and others. PATH is headquartered in Seattle, Washington, the US.

Program for Appropriate Technology in Health – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Program for Appropriate Technology in Health, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Program for Appropriate Technology in Health, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Program for Appropriate Technology in Health, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Program for Appropriate Technology in Health, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Program for Appropriate Technology in Health, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Program for Appropriate Technology in Health, Medical Equipment, Deal Details 10
Venture Financing 10
UE LifeSciences to Raise USD0.1 Million in Seed Financing 10
Partnerships 12
PATH and Mologic Enter into Agreement 12
Radboudumc and iMM Lisboa Enters Into Partnership with PATH 13
Program for Appropriate Technology in Health – Key Competitors 14
Program for Appropriate Technology in Health – Key Employees 15
Program for Appropriate Technology in Health – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Recent Developments 18
Other Significant Developments 18
Aug 10, 2017: PATH celebrates the extension of its digital health partnership with the Government of Tanzania 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Program for Appropriate Technology in Health, Medical Equipment, Key Facts 2
Program for Appropriate Technology in Health, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Program for Appropriate Technology in Health, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Program for Appropriate Technology in Health, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Program for Appropriate Technology in Health, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Program for Appropriate Technology in Health, Deals By Market, 2012 to YTD 2018 8
Program for Appropriate Technology in Health, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
UE LifeSciences to Raise USD0.1 Million in Seed Financing 10
PATH and Mologic Enter into Agreement 12
Radboudumc and iMM Lisboa Enters Into Partnership with PATH 13
Program for Appropriate Technology in Health, Key Competitors 14
Program for Appropriate Technology in Health, Key Employees 15
Program for Appropriate Technology in Health, Other Locations 16
Program for Appropriate Technology in Health, Subsidiaries 17
Program for Appropriate Technology in Health, Joint Venture 17

List of Figures
Program for Appropriate Technology in Health, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Program for Appropriate Technology in Health, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Program for Appropriate Technology in Health, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Program for Appropriate Technology in Health, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Program for Appropriate Technology in Health, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Program for Appropriate Technology in Health, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Program for Appropriate Technology in Health, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Program for Appropriate Technology in Health, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Program for Appropriate Technology in Health:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norwegian Hull Club:企業の戦略・SWOT・財務情報
    Norwegian Hull Club - Strategy, SWOT and Corporate Finance Report Summary Norwegian Hull Club - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • InterOil Corporation (IOC)-石油・ガス分野:企業M&A・提携分析
    Summary InterOil Corporation (InterOil) is an independent oil and gas company that carries out acquisition, exploration and development of oil and gas assets. It principally focuses on liquefied natural gas (LNG) projects in Papua New Guinea (PNG). It has several exploration licenses in the prospect …
  • Enel SpA (ENEL)-エネルギー分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • BioMark Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites. The company’s advanced near-to- market diagnostic technologies designed to improve patient outc …
  • ShaMaran Petroleum Corp (SNM):企業の財務・戦略的SWOT分析
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Viterra Inc.:企業の戦略・SWOT・財務情報
    Viterra Inc. - Strategy, SWOT and Corporate Finance Report Summary Viterra Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Medicom Innovation Partner as:医療機器:M&Aディール及び事業提携情報
    Summary Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device …
  • The GPT Group:企業のM&A・事業提携・投資動向
    The GPT Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The GPT Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Nitori Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ildong Pharmaceutical Co Ltd (000230):企業の財務・戦略的SWOT分析
    Summary Ildong Pharmaceutical Co Ltd (IPC) is a manufacturer of pharmaceutical products. The company offers finished drugs, health foods and foods, raw material drugs, cosmetics and medical devices and others. Its raw material drugs comprise synthesis, probiotics, vitamins and biometabolites. IPC al …
  • The North West Company Inc. (NWC):企業の財務・戦略的SWOT分析
    The North West Company Inc. (NWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Surge Energy Inc (SGY):企業の財務・戦略的SWOT分析
    Summary Surge Energy Inc (Surge) is an oil and gas company that offers acquisitions, exploration and production of crude oil and natural gas reserves. The company provides risk management and risk development drilling services. Its oil and natural gas producing properties include Shaunavon and Dodsl …
  • Nippon Soda Co Ltd (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co Ltd (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Toronto Hydro Corp:企業の戦略的SWOT分析
    Toronto Hydro Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Tersus Energy Ltd:企業の戦略的SWOT分析
    Tersus Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bachmann electronic GmbH:企業の戦略的SWOT分析
    Bachmann electronic GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Spar Nord Bank A/S:企業の戦略・SWOT・財務情報
    Spar Nord Bank A/S - Strategy, SWOT and Corporate Finance Report Summary Spar Nord Bank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cypralis Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cypralis Ltd (Cypralis), formerly Selcia Pharma Ltd is a drug developer that provides discovery and development of therapeutics targeting peptidyl-prolyl isomerases. The company spans its expertise in the development of medicines for degenerative diseases such as acute tissue injury, liver d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆